Study of homology and dissimilarity between immune-related colitis and ulcerative colitis
- Conditions
- immune-related colitis
- Registration Number
- JPRN-UMIN000036492
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Not provided
The following patients must be excluded: 1) Patients who have severe psychiatric disease. 2) Patients who are considered to be difficult to take a colonoscopy for their condition. 3) Patients who are taking two or more antithrombotic drugs and it is difficult to withdraw them for endoscopic biopsy. 4) Patients who are suspected of infectious enterocolitis, and taking some antibiotics. 5) Patients who are judged inappropriate for entry to this clinical trial by doctors. irAE-colitis group 1) Patients who suffered colitis within 4 weeks after administration of immune checkpoint inhibitors. Ulcerative colitis group 1) Not defined.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pathological findings and endoscopic findings of immune-related colitis.
- Secondary Outcome Measures
Name Time Method